"100% Patient-Driven. Physicians Research Group is dedicated to providing the medical community with the tools and processes to conduct clinical trials that further the advancement of medicine, provide treatment options that improve patient quality of life, and improved global access to health care, all while meeting and exceeding major regulatory agency requirements. Access to a large network of specialty physician practices and healthcare institutions for clinical trials. Our geographic proximity and network integration systems allow for the cross-utilization of research staff and physician collaboration that ensures the success of each project study. We are a multi-site network with a single point of accountability."

During the past decade, Lafayette Clinical Research Group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lafayette Clinical Research Group" #1 sponsor was "Pfizer" with 3 trials, followed by "BioMimetix JV, LLC" with 1 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored, "Okamoto Industries, Inc." with 1 trials sponsored and "TherapeuticsMD" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lafayette Clinical Research Group" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Innovaderm Research Inc." with 1 trials as a collaborator and "NAMSA" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Lafayette Clinical Research Group" are "Alopecia Areata" (1 trials), "Atopic Dermatitis" (1 trials), "Cancer Pain" (1 trials), "Dyspareunia" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Lafayette Clinical Research Group" in a lesser frequency.

Most popular intervention types in "Lafayette Clinical Research Group" are "Drug" (5 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "20 mg laninamivir octanoate" (1 trials), "40 mg laninamivir octanoate" (1 trials), "BMX-010" (1 trials) and "Condom" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lafayette Clinical Research Group" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lafayette Clinical Research Group". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Lafayette Clinical Research Group, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lafayette Clinical Research Group, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".